logo
Plus   Neg
Share
Email

Achillion Pharmaceuticals Inc. (ACHN) Is Climbing On EMA News

Achillion Pharmaceuticals Inc. (ACHN) announced Monday morning that its ACH-4471 received a positive opinion from the European Medicines Agency's Committee for Orphan Medicinal Products for orphan status in the European Union.

Achillion Pharmaceuticals gapped open higher this morning and has continued to rise in early trade. Shares are now up 0.32 at $3.27. The stock has climbed to a 3-month high.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT